Class IITerminated in FDA datasetOct 6, 2021

Electrolyte tablet (Calcium 10.8mg, Potassium 40mg, Magnesium 12 mg), ULTRAtab Laboratories, Inc., Highland, NY

Recalling firm: ULTRAtab Laboratories, Inc.

Why it was recalled

cGMP Deviations

Check your package

Compare the exact product and package details with the label you have.

ProductElectrolyte tablet (Calcium 10.8mg, Potassium 40mg, Magnesium 12 mg), ULTRAtab Laboratories, Inc., Highland, NY

FDA code information

Product Codes: M693 Bulk Lots: 18J001, 18J002, 18J003, 18L035, 18L036, 18M013, 18M014, 19A044, 19A045, 19B042, 19B043, 19B066, 19C006, 19C007, 19E065, 19E066, 19J045, 19J046

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Electrolyte tablet (Calcium 10.8mg, Potassium 40mg, Magnesium 12 mg), ULTRAtab Laboratories, Inc., Highland, NY

Recall details

Recall number
F-0722-2022
Event ID
89512
FDA status
Terminated
Initiated
Oct 6, 2021
Reported
Feb 16, 2022
Classified
Feb 9, 2022
Terminated
Sep 1, 2022
Quantity
26,682,419 tablets
Location
Highland, NY, United States
Initiation type
Voluntary: Firm initiated
Notification
Letter

Where it was distributed

Bulk product was distributed to 2 distributors (NY, FL) who may have repackaged the product and further distributed finished product.

FDA source record · F-0722-2022

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.